Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases

MC Patra, M Shah, S Choi - Seminars in cancer biology, 2020 - Elsevier
Immune cells of the myeloid and lymphoid lineages express Toll-like receptors (TLRs) to
recognize pathogenic components or cellular debris and activate the immune system …

Context is key: delineating the unique functions of IFNα and IFNβ in disease

LE Fox, MC Locke, DJ Lenschow - Frontiers in immunology, 2020 - frontiersin.org
Type I interferons (IFNs) are critical effector cytokines of the immune system and were
originally known for their important role in protecting against viral infections; however, they …

Oncolytic virus-derived type I interferon restricts CAR T cell therapy

L Evgin, AL Huff, P Wongthida, J Thompson… - Nature …, 2020 - nature.com
The application of adoptive T cell therapies, including those using chimeric antigen receptor
(CAR)-modified T cells, to solid tumors requires combinatorial strategies to overcome …

Diverse effects of interferon alpha on the establishment and reversal of HIV latency

RM Van der Sluis, JM Zerbato, JW Rhodes… - PLoS …, 2020 - journals.plos.org
HIV latency is the major barrier to a cure for people living with HIV (PLWH) on antiretroviral
therapy (ART) because the virus persists in long-lived non-proliferating and proliferating …

Structural integrity with functional plasticity: What type I IFN receptor polymorphisms reveal

NA de Weerd, JP Vivian, SS Lim… - Journal of Leucocyte …, 2020 - academic.oup.com
The type I IFNs activate an array of signaling pathways, which are initiated after IFNs bind
their cognate receptors, IFNα/β receptor (IFNAR) 1 and IFNAR2. These signals contribute to …